https://www.fiercebiotech.com/biotech/novartis-axes-10-pipeline-programs-narrow-rd-focus
0
0
Novartis prunes assets, axing 10% of pipeline programs to narrow R&D focus - FierceBiotech
4/25/23 at 10:50am
Organization
FierceBiotech
Author
FierceBiotech
Details
14 words
Summarize
Create an account or login to join the discussion